Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -753 | -475 | -8,206 | -7,415 | -7,456 |
| Depreciation Amortization | 102 | 38 | 6,385 | 6,083 | 6,335 |
| Accounts payable and accrued liabilities | 1 | 12 | 27 | -60 | 15 |
| Other Working Capital | 96 | 120 | -86 | 268 | 94 |
| Other Operating Activity | 61 | 74 | 560 | 176 | 313 |
| Operating Cash Flow | $-493 | $-231 | $-1,321 | $-948 | $-700 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 395 | 250 | 1,410 | 1,110 | 640 |
| Common Stock Issued | N/A | N/A | -125 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -35 | -135 | 0 |
| Financing Cash Flow | $395 | $250 | $1,250 | $975 | $640 |
| Beginning Cash Position | 190 | 190 | 262 | 262 | 262 |
| End Cash Position | 92 | 209 | 190 | 288 | 202 |
| Net Cash Flow | $-98 | $19 | $-71 | $27 | $-60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -493 | -231 | -1,321 | -948 | -700 |
| Free Cash Flow | -493 | -231 | -1,321 | -948 | -700 |